WHO releases new guidelines and gives countries a green light to use long-acting injectable

The World Health Organization-WHO on Thursday released new guidelines giving countries a green light to use long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. The guidelines that were released ahead of the annual International AIDS Conference will support countries as they plan for CAB-LA introduction as part of a comprehensive approach to HIV…

Call on big Pharma ViiV to reduce prices and share technology of long-acting injectable ARVs

Nobel laureates Françoise Barré-Sinoussi and Joseph Stiglitz, have published an open letter with a call for the price of ground-breaking new HIV medicines to be reduced dramatically so that they can be used worldwide by all who need them. Former President of Malawi Dr Joyce Banda and former New Zealand Prime Minister Helen Clark, and artists…

Two non-profits agree to fund vaginal ring development pipeline

The Population Council, a global nonprofit research organization and developer of sexual and reproductive health pharmaceuticals, and the International Partnership for Microbicides (IPM), a nonprofit organization that develops HIV prevention technologies for women, have signed an agreement for the Population Council to acquire IPM’s dapivirine vaginal ring pipeline and other assets. IPM and the Council…

Health Activists renew call for implementation of sexuality education for learners

Health activists have renewed the call to expedite the implementation of sexuality education which is key to the fight against HIV/AIDS. The appeal comes months after the high court in Kampala in November last year directed the ministry of education and sports to quickly develop and implement a comprehensive sexuality education policy for learners. According…